The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Carl L. McMillian
Advertisement
Carl L. McMillian is vice-president, Toxicology, Drug Disposition, PK/PD, Eli Lilly and Company.
Articles by Carl L. McMillian
Advertisement
Latest Updated Articles
Viewpoint: Precompetitive Collaboration Drives Pharma Industry InnovationPublished: October 15th 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
Drug Digest: Biopharma Landscape Evolves Through Strategic Alliances and Technology Integration
3
BioPharm Weekly News Roundup—Week of Nov. 24, 2025
4
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
5
